This study indicates that TGM2-knockdown in benign prostate epithelial cells can reduce cell growth and migration in a CAF-dependent manner, warranting further investigation of TGM2′s regulation and role in prostate cancer initiation and progression. This evidence concerns the gene TGM2 and prostate carcinoma.